Protara Therapeutics Inc. (TARA)
NASDAQ: TARA
· Real-Time Price · USD
3.03
-0.16 (-5.02%)
At close: Aug 15, 2025, 3:59 PM
3.09
1.98%
After-hours: Aug 15, 2025, 07:48 PM EDT
Protara Therapeutics Balance Sheet Statement
Financials in USD. Fiscal
year is
January - December.
| Fiscal Year | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 | Q2 2021 | Q1 2021 |
| Period Ending | Jun 30, 2025 | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 |
Cash & Equivalents | 31.5M | 91.46M | 162.8M | 51.76M | 89.58M | 52.23M | 39.59M | 33.77M | 33.98M | 21.04M | 24.13M | 47.5M | 33.81M | 25.44M | 35.72M | 40.74M | 46.84M | 58.2M |
Short-Term Investments | 90.72M | 32.9M | 7.49M | 29.74M | n/a | 2.99M | 25.99M | 40.27M | 46.38M | 65.58M | 60.24M | 48.82M | 64.64M | 62.16M | 55.51M | 53.02M | 37.83M | 26.14M |
Long-Term Investments | 24.14M | 33.15M | n/a | n/a | 745K | 745K | 745K | n/a | 745K | 2.89M | 17.89M | 10.76M | 14.35M | 30.89M | 39.47M | 44.65M | 60.38M | 70.82M |
Other Long-Term Assets | 3.07M | 780K | 772K | 846K | 155K | 620K | 283K | 3.69M | 2.88M | 1.33M | 1.39M | 1.48M | 1.56M | 1.53M | 1.61M | 1.69M | 1.76M | 2.88M |
Receivables | 890K | 368K | n/a | n/a | n/a | 23K | 242K | 279K | 344K | 491K | 486K | 380K | 487K | n/a | n/a | n/a | n/a | n/a |
Inventory | n/a | n/a | n/a | n/a | n/a | n/a | n/a | -279K | 3.56M | -491K | 1.16M | n/a | -487K | 2.57M | 1.22M | n/a | n/a | n/a |
Other Current Assets | 1.99M | 16K | 2K | 3.58M | 1.58M | 3K | 37K | 281K | 1K | 127K | 127K | n/a | n/a | 995K | 1.35M | 1.94M | 3.15M | 50K |
Total Current Assets | 125.09M | 126.53M | 172.16M | 85.08M | 92.21M | 57.91M | 68.7M | 77.81M | 84.27M | 94.62M | 86.15M | 98.67M | 101.09M | 90.69M | 93.11M | 95.69M | 87.82M | 87.7M |
Property-Plant & Equipment | 4.64M | 4.98M | 5.28M | 5.62M | 5.95M | 6.23M | 6.56M | 6.97M | 7.25M | 7.57M | 7.87M | 8.17M | 8.37M | 8.63M | 8.89M | 9.14M | 9.42M | 1.5M |
Goodwill & Intangibles | n/a | 3.11M | 3.25M | 2.54M | 2.58M | 2.63M | 2.66M | n/a | n/a | n/a | n/a | 29.52M | 29.52M | 29.52M | 29.52M | 29.52M | 29.52M | 29.52M |
Total Long-Term Assets | 31.84M | 42.03M | 9.3M | 9.01M | 9.43M | 10.22M | 10.25M | 10.65M | 10.88M | 11.79M | 27.14M | 49.92M | 53.79M | 70.57M | 79.48M | 85M | 101.07M | 104.72M |
Total Assets | 156.93M | 168.56M | 181.45M | 94.09M | 101.65M | 68.13M | 78.95M | 88.47M | 95.14M | 106.41M | 113.29M | 148.59M | 154.88M | 161.26M | 172.6M | 180.7M | 188.89M | 192.41M |
Account Payables | 5.3M | 2.31M | 4.43M | 2.29M | 1.39M | 972K | 2.43M | 2.5M | 1.85M | 4.08M | 1.59M | 456K | 392K | 541K | 954K | 928K | 1.4M | 1.85M |
Deferred Revenue | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 30K | 20K | 52K |
Short-Term Debt | 1.2M | n/a | n/a | n/a | n/a | 1M | 983K | 966K | 949K | 933K | 917K | 901K | 885K | 870K | 855K | 840K | 826K | 92K |
Other Current Liabilities | 1.78M | 680K | 2.53M | n/a | n/a | -1M | 1.13M | 826K | 147K | -162K | 1.63M | 133K | -116K | 115K | 946K | 615K | 175K | 413K |
Total Current Liabilities | 9.76M | 7.02M | 10.96M | 8.64M | 5.65M | 5.5M | 6.15M | 6.78M | 4.93M | 6.41M | 5.74M | 3.71M | 3.49M | 2.86M | 4.3M | 3.69M | 3.67M | 3.31M |
Long-Term Debt | 2.75M | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Other Long-Term Liabilities | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Total Long-Term Liabilities | 2.75M | 3.06M | 3.36M | 3.66M | 3.95M | 4.23M | 4.48M | 4.74M | 4.98M | 5.23M | 5.47M | 5.7M | 5.93M | 6.16M | 6.38M | 6.6M | 6.82M | 974K |
Total Liabilities | 12.51M | 10.07M | 14.32M | 12.3M | 9.6M | 9.73M | 10.63M | 11.51M | 9.92M | 11.64M | 11.21M | 9.41M | 9.43M | 9.02M | 10.68M | 10.29M | 10.49M | 4.29M |
Total Debt | 3.95M | 4.23M | 4.48M | 4.74M | 4.98M | 5.23M | 5.47M | 5.7M | 5.93M | 6.16M | 6.38M | 6.6M | 6.82M | 7.03M | 7.24M | 7.44M | 7.64M | 1.07M |
Common Stock | 39K | 39K | 35K | 21K | 21K | 11K | 11K | 11K | 11K | 11K | 11K | 11K | 11K | 11K | 11K | 11K | 11K | 11K |
Retained Earnings | -271.85M | -256.89M | -244.98M | -232.21M | -220.99M | -211.48M | -200.38M | -190.16M | -180.3M | -169.01M | -159.96M | -121M | -113.31M | -104.77M | -94.01M | -83.78M | -73.01M | -60.23M |
Comprehensive Income | 77K | 89K | 2K | 29K | n/a | -1K | -31K | -165K | -336K | -469K | -688K | -1.13M | -1.12M | -942K | -211K | -39K | -101K | -164K |
Shareholders Equity | 144.42M | 158.48M | 167.13M | 81.79M | 92.05M | 58.41M | 68.32M | 76.96M | 85.22M | 94.77M | 102.08M | 139.18M | 145.46M | 152.24M | 161.91M | 170.41M | 178.41M | 188.13M |
Total Investments | 114.86M | 66.06M | 7.49M | 29.74M | 745K | 3.74M | 26.74M | 40.27M | 46.38M | 60.24M | 78.13M | 59.58M | 78.99M | 93.04M | 94.97M | 97.67M | 98.21M | 96.97M |